{"nct_id":"NCT04135352","title":"A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic or Recurrent Malignancies (V938-001)","status":"TERMINATED","status_verified_date":"2024-09","start_date":"2019-11-04","start_date_type":"ACTUAL","primary_completion_date":"2022-08-24","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}